ArticleVeterinary world2025
Molecular surveillance confirms absence of avian influenza virus type A in Ecuadorian poultry: A retrospective reverse transcription quantitative polymerase chain reaction study from April 2023 to June 2024.
Article in Veterinary world, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Avian influenza (AI) is a highly contagious zoonotic disease affecting birds and, occasionally, humans. Ecuador confirmed its first case of AI in late 2022, resulting in significant avian mortality and economic losses. In response, the Ecuadorian government implemented a mandatory control program emphasizing pre-vaccination diagnostics using reverse transcription quantitative polymerase chain reaction (RT-qPCR) or enzyme-linked immunosorbent assay. This study aimed to confirm the absence of AI virus type A in poultry across six major provinces of Ecuador following the 2022 outbreak, as part of the national eradication and vaccination campaign. Materials and Methods: A cross-sectional, retrospective molecular surveillance study was conducted from April 2023 to June 2024. A total of 343 pooled tracheal swab samples were collected from poultry farms in six provinces (Chimborazo, Cotopaxi, El Oro, Pastaza, Pichincha, and Tungurahua), covering over 1 million birds. The samples were analyzed using real-time RT-qPCR, targeting the M gene, and subtype-specific genes (H5, H7, and H7N9). Results: All 343 pooled samples (100%) tested negative for AI virus type A, suggesting an absence of active viral circulation during the study period. The implementation of pre-vaccination testing and biosecurity protocols contributed to this outcome. Conclusion: The study confirms that AI virus type A was not circulating in Ecuadorian poultry during the surveillance period. These findings underscore the effectiveness of collaborative efforts among government, industry, and laboratories. Ongoing molecular surveillance remains essential for early detection and prevention of future outbreaks, reinforcing Ecuador's commitment to One Health principles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.